Salvatore Emma Jr., President and CEO at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), bought 1,100 shares at $6.50 ($7K) on 2015-06-15, disclosed to the SEC on 2015-06-16.
Open-market purchase of $7k HRT by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| HRT | BUY | 2015-12-31 | $137K | — | Filing → |
| HRT | SELL | 2014-08-20 | $94K | — | Filing → |